NUGC-4 Cells
USD$800.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
General information
| Description | NUGC-4 is a human gastric cancer cell line established from metastatic paragastric lymph nodes of an adult patient with poorly differentiated adenocarcinoma exhibiting focal signet-ring cell carcinoma features. The cell line was developed from tumor tissues acquired during surgical resection and has been successfully maintained both in vitro and as a transplantable tumor in nude mice. In vitro, NUGC-4 cells grow predominantly as spherical cells, with some free-floating populations, and exhibit epithelial characteristics confirmed via electron microscopy. These include well-developed endoplasmic reticulum, Golgi apparatus, cytoplasmic filaments, and desmosome-like junctions. Notably, cells contain intracytoplasmic microcysts, contributing to their unique morphology. Chromosomal analysis reveals that NUGC-4 cells possess a near-triploid karyotype with a modal chromosome number ranging from 52 to 54 in vitro and approximately 53 in vivo. The cells display consistent trisomies across several chromosomal groups, though no specific marker chromosomes were identified. Doubling time for NUGC-4 is approximately 29.9 hours, indicating a moderately rapid proliferation rate under standard culture conditions. Among three related gastric cancer lines (NUGC-2, NUGC-3, and NUGC-4), NUGC-4 exhibited the highest in vitro sensitivity to anticancer agents such as mitomycin C and adriamycin, suggesting a heightened responsiveness to certain DNA-damaging chemotherapeutics. Histologically, xenografts derived from NUGC-4 resemble the parent tumor, maintaining features of a scirrhous carcinoma pattern. The line has been used in drug response profiling and molecular characterization studies as part of large-scale cancer cell line projects. Its combination of clinical origin, histological fidelity, and drug sensitivity profile makes NUGC-4 a relevant model for studying aggressive and chemoresponsive gastric adenocarcinomas with diffuse-type characteristics. |
|---|---|
| Organism | Human |
| Tissue | Metastatic |
| Disease | Gastric signet ring cell adenocarcinoma |
| Synonyms | NUGC4, NU-GC-4, Nagoya University-Gastric Cancer-4 |
Characteristics
| Age | 35 years |
|---|---|
| Gender | Female |
| Ethnicity | Japanese |
Regulatory Data
| Citation | NUGC-4 (Cytion catalog number 305645) |
|---|---|
| NCBI_TaxID | 9606 |
| CellosaurusAccession | CVCL_3082 |
Biomolecular Data
| Mutational profile | Mutation: TP53, None_reported, -, - (PubMed=1370612, PubMed=15900046). |
|---|
Handling
| Doubling time | 29 |
|---|---|
| Freeze medium | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality Control & Molecular Analysis
| Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
| Metastatic site: | Lymph node |
|---|
Certificate of Analysis (CoA)
| Lot Number | Certificate Type | Date | Catalog Number |
|---|---|---|---|
| 305645-090326 | Certificate of Analysis | 31. Mar. 2026 | 305645 |